000300742 001__ 300742
000300742 005__ 20250602152229.0
000300742 0247_ $$2doi$$a10.1111/cea.70066
000300742 0247_ $$2pmid$$apmid:40295156
000300742 0247_ $$2ISSN$$a0954-7894
000300742 0247_ $$2ISSN$$a0009-9090
000300742 0247_ $$2ISSN$$a1365-2222
000300742 0247_ $$2altmetric$$aaltmetric:176645189
000300742 037__ $$aDKFZ-2025-00902
000300742 041__ $$aEnglish
000300742 082__ $$a610
000300742 1001_ $$aPeng, Zhuoxin$$b0
000300742 245__ $$aChanges in Childhood Atopic Dermatitis Incidence and Risk Factors Over Time: Results From Two German Birth Cohorts.
000300742 260__ $$aOxford$$bBlackwell Science$$c2025
000300742 3367_ $$2DRIVER$$aarticle
000300742 3367_ $$2DataCite$$aOutput Types/Journal article
000300742 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1748870503_11125
000300742 3367_ $$2BibTeX$$aARTICLE
000300742 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300742 3367_ $$00$$2EndNote$$aJournal Article
000300742 500__ $$a2025 Jun;55(6):469-480
000300742 520__ $$aAtopic dermatitis (AD) is a common allergic skin disease. We aimed to assess the secular changes in the cumulative incidence of childhood AD and its risk factors over a decade.We used data from two methodologically similar cohort studies in Ulm, Germany, the Ulm Birth Cohort Study (UBCS, recruited in 2000/2001) and the Ulm SPATZ Health Study (recruited in 2012/2013). The cumulative incidences of AD as reported by their family physicians and parents up to the age of 4 years were compared by log-rank test across the two cohorts, using propensity score-based weighting to control confounders. We fitted multivariable Cox regression models to estimate hazard ratios and 95% confidence intervals (CIs) for the factors associated with the occurrence of physician- and parent-reported AD and compared the results between the two cohorts.The 4-year cumulative incidence (95% confidence interval) of physician-reported AD (27.4% (24.4%-30.5%) in UBCS [2000/2001] vs. 26.4% (22.8%-30.2%) in SPATZ [2012/2013], p = 0.728) and parent-reported AD (14.5% (12.2%-17.0%) in UBCS [2000/2001] vs. 16.7% (14.0%-19.7%) in SPATZ [2012/2013], p = 0.211) remained stable between the two cohorts after propensity score-based weighting. We observed the changes in the association between AD and certain risk factors (e.g., family history of AD and infantile antibiotic use) over the decade, but the results need to be interpreted with caution due to the limited sample size, relatively high attrition rate and demographic differences between the two cohorts.Over the decade, childhood AD incidence remained stable. Further studies are needed to verify whether there is a growing importance of environmental and microbiota-related factors for AD development over time.
000300742 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000300742 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000300742 650_7 $$2Other$$aatopic dermatitis
000300742 650_7 $$2Other$$acumulative incidence
000300742 650_7 $$2Other$$aenvironment
000300742 650_7 $$2Other$$amicrobiota
000300742 650_7 $$2Other$$arisk factors
000300742 7001_ $$00000-0002-4773-252X$$aSiziba, Linda P$$b1
000300742 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b2$$udkfz
000300742 7001_ $$aWernecke, Deborah$$b3
000300742 7001_ $$aRothenbacher, Dietrich$$b4
000300742 7001_ $$00000-0001-5764-1528$$aGenuneit, Jon$$b5
000300742 773__ $$0PERI:(DE-600)2004469-0$$a10.1111/cea.70066$$gp. cea.70066$$n6$$p469-480$$tClinical & experimental allergy$$v55$$x0954-7894$$y2025
000300742 909CO $$ooai:inrepo02.dkfz.de:300742$$pVDB
000300742 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000300742 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000300742 9141_ $$y2025
000300742 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-13$$wger
000300742 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2024-12-13$$wger
000300742 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN EXP ALLERGY : 2022$$d2024-12-13
000300742 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCLIN EXP ALLERGY : 2022$$d2024-12-13
000300742 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie der Krebsfrüherkennung$$x0
000300742 980__ $$ajournal
000300742 980__ $$aVDB
000300742 980__ $$aI:(DE-He78)C070-20160331
000300742 980__ $$aUNRESTRICTED